Judo Bio – Talk Bio

Actionable Insights Powered by AI

Judo Bio Launches with $100M to Pioneer Kidney-Targeted siRNA Therapies

7 months ago talkbio0Tagged genetic medicines, Judo Bio, Kidney Diseases, megalin-STRIKERS, oligonucleotide medicines, RNA, Small Interfering, Strikes, Employee

Judo Bio, siRNA therapies, kidney diseases, oligonucleotide medicines, STRIKE platform, megalin-STRIKERS, renal diseases, genetic medicines.

Judo Bio Launches with $100 Million to Revolutionize Kidney Drug Delivery

7 months ago talkbio0Tagged biotech startup, Judo Bio, kidney drug

Judo Bio, Kidney drug delivery, Biotech startup, Pharmaceutical innovation, $100 million funding